TIAA CREF Investment Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

TIAA CREF Investment Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-15,798	Closed	-$54K	–	3221
2017 Q1	$54K	Hold	15,798	–	–	﹤0.01%	3060
2016 Q4	$82K	Sell	15,798 -668	-4%	-$11.6K	﹤0.01%	3093
2016 Q3	$415	Sell	16,466 -10,091	-38%	-$254K	﹤0.01%	2924
2016 Q2	$656K	Buy	26,557 +468	+2%	+$13.2K	﹤0.01%	2750
2016 Q1	$756K	Sell	26,089 -236	-0.9%	-$6.4K	﹤0.01%	2619
2015 Q4	$977K	Hold	26,325	–	–	﹤0.01%	2597
2015 Q3	$1.28M	Buy	26,325 +2,910	+12%	+$203K	﹤0.01%	2419
2015 Q2	$1.61M	Buy	+23,415	New	+$1.08M	﹤0.01%	2431

Other funds holding ANTH

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

TIAA CREF Investment Management's ANTH Position: Q2 2017 in Review

TIAA CREF Investment Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2017, closing a stake of 15,798 shares — an estimated $54K sold.

TIAA CREF Investment Management first reported a position in ANTH in Q2 2015 and held it in 8 quarters. The position peaked at $1.61M in Q2 2015. 40 funds tracked by Wall St. Rank hold ANTH as of Q2 2017.

TIAA CREF Investment Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
TIAA CREF Investment Management sold 15,798 Anthera Pharmaceuticals, Inc. shares in Q2 2017, an estimated $54K.
TIAA CREF Investment Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and held it in 8 quarters.
TIAA CREF Investment Management's Anthera Pharmaceuticals, Inc. position peaked at $1.61M in Q2 2015.
40 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2017.

Based on TIAA CREF Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.